Spontaneous gross haematuria during dabigatran therapy for secondary stroke prevention

Thromb Haemost. 2012 Sep;108(3):579-81. doi: 10.1160/TH12-03-0156. Epub 2012 Jun 28.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenocarcinoma / blood
  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / secondary
  • Aged, 80 and over
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Antithrombins / adverse effects*
  • Antithrombins / pharmacokinetics
  • Antithrombins / therapeutic use
  • Atrial Fibrillation / complications
  • Benzimidazoles / adverse effects*
  • Benzimidazoles / pharmacokinetics
  • Benzimidazoles / therapeutic use
  • Bone Neoplasms / blood
  • Bone Neoplasms / drug therapy
  • Bone Neoplasms / secondary
  • Brain Ischemia / etiology
  • Brain Ischemia / prevention & control*
  • Comorbidity
  • Dabigatran
  • Hematuria / chemically induced*
  • Humans
  • Kidney Failure, Chronic / blood
  • Kidney Failure, Chronic / complications
  • Leuprolide / therapeutic use
  • Male
  • Prostatic Neoplasms / blood
  • Prostatic Neoplasms / drug therapy
  • Pulmonary Disease, Chronic Obstructive / blood
  • Pulmonary Disease, Chronic Obstructive / complications
  • Secondary Prevention
  • Thrombophilia / drug therapy*
  • Thrombophilia / etiology
  • Urinary Retention / chemically induced
  • beta-Alanine / adverse effects
  • beta-Alanine / analogs & derivatives*
  • beta-Alanine / pharmacokinetics
  • beta-Alanine / therapeutic use

Substances

  • Antineoplastic Agents, Hormonal
  • Antithrombins
  • Benzimidazoles
  • beta-Alanine
  • Leuprolide
  • Dabigatran